Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest Fact.MR analysis, the global hepatitis rapid testing market is forecast to register high growth between 2021 and 2031.
Innovations in Point of Care Testing Contribute Towards Swift Expansion of Hepatitis Rapid Testing Market
A Fact.MR survey on hepatitis rapid testing market offers detailed analysis on growth drivers and trends affecting demand in terms of product type, test type, usage, ender user and region. It also highlights various strategies adopted by key market players to gain a competitive edge in the Hepatitis rapid testing market.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per the latest Fact.MR analysis, the global hepatitis rapid testing market is forecast to register high growth between 2021 and 2031. Rise in cases of hepatitis is the primary factor driving the hepatitis rapid testing market. According to the World Health Organization (WHO), around 325 million people live with a hepatitis infection worldwide.
Besides this, growing popularity of point of care diagnostics, and various initiatives undertaken by governments and private organizations to offer advanced healthcare will create lucrative growth opportunities for the market.
Growing awareness among people regarding hepatitis and its consequences is creating high demand for rapid hepatitis diagnostic tests. As a result, the market has been forecast to exhibit growth at a positive rate through 2031.
Request a report sample to gain compressive insights at
https://www.factmr.com/connectus/sample?flag=B&rep_id=6884
Some viral hepatitis forms such as hepatitis B and C might lead to serious health concerns such as liver cirrhosis, liver cancer and even death. Early detection of hepatitis has therefore become necessary to prevent the further spread of infection and reduce the mortality rate.
As per the WHO, around 4.5 million premature deaths can be prevented in low- and middle-income countries by 2030 through early diagnosis, vaccination, medicine, and education campaigns.
Key Takeaways from Hepatitis Rapid Testing Market Survey
- North America leads the hepatitis rapid testing market owing to high prevalence of hepatitis cases, heavy alcohol consumption and advances in diagnostic research.
- The Europe market is exhibiting positive growth as a result of rising hepatitis cases and growing demand for better and fast diagnostic procedures.
- With increasing patient pool, changing lifestyle, continuous advances in hepatitis treatment and the presence of leading clinical laboratories, the U.S. has emerged as the most lucrative market for hepatitis rapid testing.
- Immunoassay tests category is anticipated to account for the highest growth during the forecast period.
- Based on end users, the hospital and diagnostic centers segments are expected to hold the maximum share during the forecast period.
Key Drivers
- Increasing prevalence of hepatitis is primarily driving the hepatitis rapid testing market.
- Growing awareness among people regarding benefits of early diagnosis of hepatitis will bode well for the market.
- Changing lifestyle along with high consumption of alcohol and other drugs, which often are related to the increasing prevalence of liver health concerns, also will fuel demand in the market.
Key Restraints
- High cost of hepatitis tests like molecular tests is restraining the growth of hepatitis rapid testing market.
- Low penetration of advanced technologies for hepatitis testing in low and middle-income economies also limits the market growth.
To gain in-depth insights on Hepatitis Rapid Testing Market, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6884
Competitive Landscape
Key players operating in the hepatitis rapid testing market are focusing on developing efficient and affordable diagnostic products. They have adopted various organic and inorganic strategies such as new product launches, mergers and acquisitions, partnerships and collaborations to gain a competitive edge in the market.
- In May 2021, Biosynex SA acquired Avalun SAS to become the European leader in rapid diagnostic testing. The acquisition will help the company to expand its presence.
- In February 2019, Abbot introduced the world’s most sensitive rapid diagnostic test, Determine HBsAg 2, for the detection of hepatitis B.
- In July 2021, the Drugs for Neglected Diseases initiative (DNDi), Medecins Sans Frontiers (MSF), Find, the global alliance for diagnostics and the Treatment Action Group joined forces to tackle silent epidemic of hepatitis C. The Hepatitis C PACT will foster an enabling environment for testing and treatment for hepatitis.
Some of the prominent players operating in the Hepatitis rapid testing market profiled by Fact.MR are:
- Abbott
- Standard Diagnostics Inc
- DiaSorin S.p.A
- SD Biosensor
- Kehua-Bio-Engineering Co. Ltd.
- bioMerieux SA
- Biokit S.A.
- RPC Diagnostics System
- Dia Pro- Diagnostic Bioprobes s.r.l.
- Creative Diagnostics
- Asan Pharm Co. Ltd.
- Fujirebio
- Orasure Technologies
- InTec Products Inc.
- Bio-Rad Laboratories Inc
- Sysmex Asia Pacific Pte Ltd.
- F. Hoffmann- La Roche Ltd
More Insights on the Global Hepatitis Rapid Testing Sales Outlook
Fact.MR provides an unbiased analysis of hepatitis rapid testing market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global demand for hepatitis rapid testing with a detailed segmentation on the basis of:
Product Type
- Test Strip
- Cassette
Test Type
- Rapid Diagnostic Tests/ Point-of-care Tests
- Immunoassay Tests
- ELISA Kits
- Enzyme Immunoassay kit
- Molecular assay Tests
- Nucleic Acid Test/ PCR test
Usage
- Clinical Diagnostics
- Academic Research Centers
End Users
- Diagnostic Centers
- Pathology Laboratories
- Research Centers
- Specialty Clinics
- Hospitals
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Key Questions Covered in the Hepatitis Rapid Testing Sales Outlook Report
- The report offers insight into hepatitis rapid testing demand outlook for 2021-2031
- The market study also highlights projected sales growth for hepatitis rapid testing market between 2021 and 2031
- Hepatitis rapid testing market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Hepatitis rapid testing market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Immunoassay Market- The database of biomarkers utilized by industry participants to design new assays that detect the onset of a disease or ailment has grown as a result of rapid advances in genomes and proteomics. The global immunoassays market is expected to grow at a rapid pace. Rising demand for early detection and diagnosis of autoimmune illnesses has prompted major participants in the in-vitro diagnostics business to create new immunoassay systems. In addition, the current COVID-19 pandemic has encouraged major businesses to invest extensively in the development of SARS-CoV-2 virus immunoassays.
PCR and Real-time PCR Molecular Diagnostics Market- The use of polymerase chain reaction (PCR) molecular diagnostics has increased dramatically in recent years. For several infectious disorders, PCR assays are quite successful at detecting harmful DNA. To find cures for life-threatening illnesses, researchers are working to expand the coverage of PCR and RT-PCR tests. The COVID-19 pandemic has boosted the demand for PCR and real-time PCR molecular diagnostics in particular. To detect and diagnose probable cases, real-time (qPCR) and digital (dPCR) PCR assays have been used in a variety of healthcare settings.
Rapid Medical Diagnostic Kits Market- Infectious disease incidence has been steadily increasing over the last few decades, driving up demand for rapid medical diagnostic kits around the world. The need to detect novel pathogens that cause diseases is propelling the market forward. The low cost of rapid medical diagnostic kits is propelling market growth. Blood glucose testing is in high demand, and it has been growing at the quickest rate of all types of tests across all geographies. Technology advancements and strategic alliances by key market players have paved the way for rapid medical diagnostic kit innovations.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR